Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Journey
Companies On The Road
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Journey
Companies On The Road
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
Nice Insight Reports
2022 Sterile
2023 Cell & Gene Therapy
2023 mAb and Recombinant Protein
2024 API
2024 OSD
2024 ADC
2024 mRNA
2024 Mammalian Cell Culture
2024 Microbial Cell Culture
2024 Plasmids
2024 Gene Therapy
2024 Cell Therapy
2024 Sterile
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
Financing (2)
46 Articles Available
2
2
Can't find what you're looking for? Try our
advanced search
.
Financing
IGM Biosciences Announces $102 Million Series C Financing to Advance its IgM Antibody Platform and Pipeline
PR-M07-19-NI-028
Funding
Esperion Raises an Additional $200 Million
PAO-M07-19-NI-015
Series B Financing
BioNTech Raises USD 325 Million in an Upsized Series B Financing to Further Advance Individualized Immuno-Oncology Pipeline
PR-M07-19-NI-025
Series B Financing
DayTwo Secures $31 Million In Series B Financing To Scale Microbiome Research Platform To Address Chronic Health Conditions
PR-M06-19-NI-059
Series B Financing
Purigen Biosystems Raises $26.4 Million Series B Financing to Accelerate Commercialization of Automated Sample Preparation Platform
PR-M06-19-NI-055
Series A Financing
Tangen Biosciences Announces $9 Million Series A Financing to Accelerate Development of Disruptive Molecular Diagnostic Platform
PR-M06-19-NI-041
Series B Financing
Purigen Biosystems Raises $26.4 Million Series B Financing to Accelerate Commercialization of Automated Sample Preparation Platform
PR-M06-19-NI-022
Financing
Schrödinger Announces Close of Latest Financing, Raising a Total of $110 Million
PR-M05-19-NI-062
Financing
Actuate Therapeutics Completes $21.7 Million Series B Financing
PR-M05-19-NI-061
Financing
KNOW Bio Announces Closing of $30 Million in Equity Financing
PR-M05-19-NI-048
Investment
Bayer Invests $150 Million to Build New Cell Culture Technology Center in Berkeley to Spur Innovation of Biotech Therapies
PR-M05-19-NI-040
Series B Financing
ABK Biomedical Raises $30M in Series B Financing
PR-M04-19-NI-039
Finance
First Light Diagnostics Closes $8.25 Million Series A-2 Financing
PR-M01-19-NI-058
Investment
Antengene Benefits from Second-Round Financing
PAO-M01-19-NI-008
Investment
Connect Biopharmaceuticals Completes $55 Million Series B Financing to Accelerate Clinical Development of Novel Immune Modulators
PR-M01-19-NI-005
Financing
Entrada Therapeutics Raises $59 Million Series A to Advance Intracellular Biologics Platform
PR-M12-18-NI-081
Public Offering
Biohaven Announces Proposed Public Offering of Common Shares
PR-M12-18-NI-060
Financing
Impel NeuroPharma Closes $67.5 Million Series D Financing
PR-M12-18-NI-040
Financing
Antios Therapeutics Raises $25 Million in Oversubscribed Series A Financing to Pursue Hepatitis B Cure
PR-M11-18-NI-100
Investment
Qpex Biopharma Announces Closing of $33 Million Series A Financing and Launch of Company to Address Worldwide Problem of Drug-Resistant Infections
PR-M10-18-NI-087
Investment
Artios Pharma Receives $84 million in Series B Funding
PAO-M08-18-NI-014
Financing
Wuxi Vision Pro Ltd. has completed B round financing of RMB 80 million from Qiming Venture, etc. to accelerate "Domestic Era" in the treatment of cataracts in China
PR-M05-18-NI-035
«
2
2
.svg)
